Skip to main content
Masimo's O3 Regional Oximetry cleared by FDA for neonates, infants
6/11/2019

Masimo has obtained additional 510(k) clearance from the FDA for its O3 Regional Oximetry platform for use in neonates and infants. The system monitors the hemoglobin oxygen saturation of blood on both sides of the brain using near-infrared spectroscopy.

Full Story: